
基本信息:
- 专利标题: 喜树碱在制备治疗乙型病毒性肝炎的药物中的应用
- 专利标题(英):Application of camptothecin to preparation of drugs used for treating viral hepatitis B
- 申请号:CN201710151299.4 申请日:2017-03-14
- 公开(公告)号:CN108567779A 公开(公告)日:2018-09-25
- 发明人: 于琦 , 卢学春 , 贺培风 , 王勤英
- 申请人: 山西医科大学
- 申请人地址: 山西省太原市迎泽区新建南路56号
- 专利权人: 山西医科大学
- 当前专利权人: 山西医科大学
- 当前专利权人地址: 山西省太原市迎泽区新建南路56号
- 代理机构: 北京知本村知识产权代理事务所
- 代理人: 刘江良
- 主分类号: A61K31/4745
- IPC分类号: A61K31/4745 ; A61P31/20
The invention discloses application of camptothecin to preparation of drugs used for treating viral hepatitis B. Camptothecin has obvious inhibitory effect on HBsAg and HBeAg at a maximum non-toxic dose, and with the increase of the concentration of chaetocin, the inhibitory effect is more obvious, showing a concentration-dose-dependent relationship. Camptothecin also has obvious inhibitory effecton HBV DNA at a maximum non-toxic dose, and with the increase of the concentration of chaetocin, the inhibitory effect is more obvious, showing a concentration/dose-dependent relationship. Camptothecin provided by the invention can completely eliminate hepatitis B viruses in patients with hepatitis B, has small toxic and side effects and different action sites, is economical and cheap, and is expected to become a novel anti-HBV therapeutic drug.
公开/授权文献:
- CN108567779B 喜树碱在制备治疗乙型病毒性肝炎的药物中的应用 公开/授权日:2020-11-06
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/33 | .杂环化合物 |
----------A61K31/335 | ..仅有氧作为环杂原子的,例如制霉色基素 |
------------A61K31/40 | ...有仅以1个氮作为环杂原子的五元环的,例如舒必利、琥珀酰亚胺、托尔米丁、甲氧吡丁苯 |
--------------A61K31/47 | ....喹啉;异喹啉 |
----------------A61K31/4738 | .....与杂环邻位或迫位稠合的 |
------------------A61K31/4745 | ......与有氮作为环杂原子的环稠合的,例如菲咯啉 |